 |
|
|
|
|
|
|
|
|
|
|
|
1 to 9 of 9 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Roberts G. on LIVE DISCUSSION: Resolving Controversies on the Path to AD Therapeutics, Dennis Selkoe's Perspective is illuminating. The glass is half full. 7 Sep 2011.
|
|
|
 |
|
|
Roberts G. on NEWS: Bad Guys—Aβ Oligomers Live Up to Reputation in Human Studies, Recommendation Only. 7 May 2010.
|
|
|
|
|
|
Roberts G. on NEWS: Chew the Fat—Lipids, NMDARs Mediate Neuronal Response to Aβ, I believe the anti-TNF Alzheimer's studies authored by Edward Tobinick and mentioned in this... 23 Nov 2009.
|
|
|
|
|
|
Roberts G. on NEWS: Washington: More Highlights from Drug Discovery Meeting, Part 2, Congratulations to Howard Fillit, ADDF, and all the contributors for sharing. This is the way... 1 Apr 2008.
|
|
|
|
|
|
Roberts G. on NEWS: Amyloid Imaging: Laying PIB Concerns to Rest, New diagnostics go hand in hand with new therapies. Are we there yet! Roll on the summer months! 1 Apr 2008.
|
|
|
|
|
|
Roberts G. on NEWS: Breakthrough or False Hope? Etanercept Case Report Draws Scrutiny, Should elderly Alzheimer disease patients be exposed to off-label administration of a drug that... 1 Feb 2008.
|
|
|
|
|
|
Roberts G. on Early-Onset Familial AD: Alzheimer Disease in Mid-life, I congratulate Gabrielle Strobel for highlighting the historic AD therapeutic research role of... 10 Jul 2007.
|
|
|
|
|
|
Roberts G. on NEWS: Tuebingen: Researchers Reminisce, Predict at Alzheimer Centennial, What a celebration of past and present pioneers in the field of Alzheimer's. I give it *****... 17 Nov 2006.
|
|
|
|
|
|
Roberts G. on NEWS: Tuebingen: Researchers Reminisce, Predict at Alzheimer Centennial, If you have the slightest interest in the history of Alzheimer's Disease and its potential... 17 Nov 2006.
|
|
|
|
|
|
|
1 to 9 of 9 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
